Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

8.745 +0.005 (+0.06%)

Streaming Delayed Price Updated: 9:30 AM EDT, Aug 4, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	8,064
Open	8.745
Bid (Size)	8.670 (400)
Ask (Size)	8.740 (400)
Prev. Close	8.740
Today's Range	8.745 - 8.745
52wk Range	7.210 - 20.46
Shares Outstanding	196,357,149
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ADMA BIOLOGICS CLASS ACTION DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. Stockholders to Contact the Firm Regarding Their Rights Before August 10th

August 03, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 03, 2026

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 3, 2026) - Kahn Swick & Foti, LLC ("KSF")...

Via Newsfile

Performance

YTD	-51.1%	-51.1%
1 Month	-4.5%	-4.5%
3 Month	-15.2%	-15.2%
6 Month	-50.0%	-50.0%
1 Year	-56.1%	-56.1%

More News

ADMA BIOLOGICS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

August 03, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law

August 03, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

July 31, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 31, 2026

Via Newsfile

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

July 31, 2026

From Lowey Dannenberg, P.C.

Via GlobeNewswire

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

July 30, 2026

From SkyMedia, LLC

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 29, 2026

Via Newsfile

ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 10, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

July 29, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026

July 29, 2026

From ADMA Biologics, Inc.

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 28, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ADMA

July 28, 2026

From Pomerantz LLP

Via GlobeNewswire

ADMA BIOLOGICS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA

July 28, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 27, 2026

Via Newsfile

July 25, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 24, 2026

Via Newsfile

ADMA BIOLOGICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. Stockholders to Contact the Firm Regarding Their Rights Before August 10th

July 23, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

July 23, 2026

From SkyMedia, LLC

Via GlobeNewswire

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

July 23, 2026

From Schall Law

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. (ADMA)

July 23, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 22, 2026

Via Newsfile

ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA

July 22, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 10, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

July 22, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 21, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

Frequently Asked Questions

Is ADMA Biologics Inc - Common Stock publicly traded?

Yes, ADMA Biologics Inc - Common Stock is publicly traded.

What exchange does ADMA Biologics Inc - Common Stock trade on?

ADMA Biologics Inc - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for ADMA Biologics Inc - Common Stock?

The ticker symbol for ADMA Biologics Inc - Common Stock is ADMA on the Nasdaq Stock Market

What is the current price of ADMA Biologics Inc - Common Stock?

The current price of ADMA Biologics Inc - Common Stock is 8.745

When was ADMA Biologics Inc - Common Stock last traded?

The last trade of ADMA Biologics Inc - Common Stock was at 08/04/26 09:30 AM ET

What is the market capitalization of ADMA Biologics Inc - Common Stock?

The market capitalization of ADMA Biologics Inc - Common Stock is 1.72B

How many shares of ADMA Biologics Inc - Common Stock are outstanding?

ADMA Biologics Inc - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.